S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

AngioDynamics (ANGO) Earnings Date, Estimates & Call Transcripts

$6.33
-0.18 (-2.76%)
(As of 04/17/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ANGO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANGO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AngioDynamics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243($0.14)$0.00($0.09) 
Q2 20243($0.08)$0.03($0.04) 
Q3 20243($0.15)$0.03($0.08) 
Q4 20243($0.10)$0.09($0.03) 
FY 202412($0.47)$0.15($0.25) 
Q1 20252($0.19)($0.11)($0.15) 
Q2 20252($0.12)($0.05)($0.09) 
Q3 20252($0.07)($0.06)($0.07) 
Q4 20252($0.08)$0.02($0.03) 
FY 20258($0.46)($0.20)($0.33) 
Q1 20261($0.13)($0.13)($0.13) 
Q2 20261($0.03)($0.03)($0.03) 
Q3 20261$0.01$0.01$0.01 

ANGO Earnings Date and Information

AngioDynamics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 10th, 2024 based off prior year's report dates.

AngioDynamics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/10/2024
Estimated)
------- 
1/5/2024Q2 2024($0.09)($0.05)+$0.04$0.62$81.65 million$79.07 million
10/4/2023Q1 2024($0.13)($0.12)+$0.01($1.39)$77.70 million$78.70 million    
7/12/2023Q2 2023$0.02$0.02-$0.58$90.73 million$91.10 million    
3/30/2023Q3 2023($0.01)($0.03)($0.02)$0.18$83.20 million$80.70 million    
1/5/2023Q2 2023($0.01)$0.01+$0.02$0.23$84.05 million$85.43 million
10/6/2022Q1 2023($0.02)($0.06)($0.04)$0.21$83.43 million$81.50 million    
7/12/2022Q4 2022$0.01$0.01-$0.18$82.91 million$87.00 million    
4/7/2022Q3 2022($0.01)$0.03+$0.04$0.19$76.32 million$74.00 million    
1/5/2022Q4 2021$0.0050($0.02)($0.0250)$0.17$77.90 million$78.30 million    
9/30/2021Q3 2021($0.05)($0.02)+$0.03$0.14$71.31 million$77.00 million    

AngioDynamics Earnings - Frequently Asked Questions

When is AngioDynamics's earnings date?

AngioDynamics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 10th, 2024 based off last year's report dates. Learn more on ANGO's earnings history.

How much revenue does AngioDynamics generate each year?

AngioDynamics (NASDAQ:ANGO) has a recorded annual revenue of $338.75 million.

How much profit does AngioDynamics generate each year?

AngioDynamics (NASDAQ:ANGO) has a recorded net income of -$52.44 million. ANGO has generated -$4.84 earnings per share over the last four quarters.

What is AngioDynamics's EPS forecast for next year?

AngioDynamics's earnings are expected to grow from ($0.57) per share to ($0.55) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ANGO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners